We are live on ! Find out more
YARW

Yarrow Bioscience, Inc. Common Stock
YARW

49 hedge funds and large institutions have $12.5M invested in Yarrow Bioscience, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

265% more call options, than puts

Call options by funds: $95K | Put options by funds: $26K

0.01% less ownership

Funds ownership: 0.03% → 0.03% (-0.01%)

16% less funds holding

Funds holding: 58 → 49 (-9)

38% less capital invested

Capital invested by funds: $20.1M → $12.5M (-$7.62M)

38% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 13

44% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 18

Holders
49
Holders Change
-9
Holders Change %
-15.52%
% of All Funds
0.75%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
10
Increased
8
Reduced
13
Closed
18
Calls
$95K
Puts
$26K
Net Calls
+$69K
Net Calls Change
-$39K

Top Buyers

Rank Fund Capital Flow
1
DA
DSC Advisors
Illinois
+$1.73M
2
Marshall Wace
Marshall Wace
United Kingdom
+$196K
3
GCP
GSA Capital Partners
United Kingdom
+$149K
4
Goldman Sachs
Goldman Sachs
New York
+$88K
5
VF
Virtu Financial
New York
+$80.5K

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$2.12M
2
6CM
683 Capital Management
New York
-$994K
3
Renaissance Technologies
Renaissance Technologies
New York
-$406K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$226K
5
CM
CM Management
Florida
-$200K
Name Holding Trade Value Shares
Change 		Change in
Stake
SW
26
SkyOak Wealth
Michigan
$28K +$32.2K +30 New
Bank of New York Mellon
27
Bank of New York Mellon
New York
$27K – – –
CL
28
CSS LLC
Illinois
$26K – – –
Jane Street
29
Jane Street
New York
$26K +$30K +28 New
Ameriprise
30
Ameriprise
Minnesota
$22K -$12.9K -12 -33%
Commonwealth Equity Services
31
Commonwealth Equity Services
Massachusetts
$20K – – –
T. Rowe Price Associates
32
T. Rowe Price Associates
Maryland
$20K – – –
LPL Financial
33
LPL Financial
California
$18K – – –
XT
34
XTX Topco
Cayman Islands
$17K +$20.4K +19 New
TRCT
35
Tower Research Capital (TRC)
New York
$8K +$3.22K +3 +50%
Russell Investments Group
36
Russell Investments Group
United Kingdom
$3K – – –
SPIA
37
Steward Partners Investment Advisory
New York
$2K -$2.15K -2 -50%
Federated Hermes
38
Federated Hermes
Pennsylvania
$2K – – –
Fidelity Investments
39
Fidelity Investments
Massachusetts
$2K – – –
First Manhattan
40
First Manhattan
New York
$2K – – –
PNC Financial Services Group
41
PNC Financial Services Group
Pennsylvania
$2K +$2.15K +2 New
Simplex Trading
42
Simplex Trading
Illinois
$2K +$2.15K +2 New
SWM
43
Spire Wealth Management
Virginia
$2K +$2.15K +2 New
MIFH
44
Migdal Insurance & Financial Holdings
Israel
$1K -$1.07K -1 -50%
Northwestern Mutual Wealth Management
45
Northwestern Mutual Wealth Management
Wisconsin
$1K – – –
Osaic Holdings
46
Osaic Holdings
Arizona
$1K – – –
Rockefeller Capital Management
47
Rockefeller Capital Management
New York
$1K – – –
Royal Bank of Canada
48
Royal Bank of Canada
Ontario, Canada
$1K – – –
Wells Fargo
49
Wells Fargo
California
$1K +$2.15K +2 New
6CM
50
683 Capital Management
New York
– -$994K -795 Closed
1
2
3

YARW Hedge Fund Activity: Q4 2021 in Review

49 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Yarrow Bioscience, Inc. Common Stock (YARW) for Q4 2021, worth a combined $12.5M — down 38% from $20.1M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of YARW and 10 opened new positions — a net loss of 8 holders — while 13 trimmed existing stakes and 8 added.

The largest buyer was DSC Advisors, adding an estimated $1.73M. The largest seller was Franklin Resources, cutting an estimated $2.12M.

  • 49 institutional investors held Yarrow Bioscience, Inc. Common Stock (YARW) as of Q4 2021, down from 58 in Q3 2021.
  • Funds reported $12.5M of Yarrow Bioscience, Inc. Common Stock stock for Q4 2021, down 38% quarter-over-quarter.
  • 10 funds opened new Yarrow Bioscience, Inc. Common Stock positions in Q4 2021 and 18 closed out, a net change of -8 holders.
  • The largest Yarrow Bioscience, Inc. Common Stock buyer in Q4 2021 was DSC Advisors, an estimated $1.73M added.
  • The largest Yarrow Bioscience, Inc. Common Stock seller in Q4 2021 was Franklin Resources, an estimated $2.12M sold.

Based on aggregated 13F filings for Q4 2021.